{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:31:56Z","timestamp":1789975916661,"version":"4.0.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2679,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/jid.2008.31","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T11:32:07Z","timestamp":1205407927000},"page":"1977-1980","source":"Crossref","is-referenced-by-count":7,"title":["Lack of Functionally Active Melan-A26\u201335-Specific T Cells in the Blood of HLA-A2+ Vitiligo Patients"],"prefix":"10.1016","volume":"128","author":[{"given":"Sylvia","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Schachterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2008.31_bb0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"Garbelli","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2008.31_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003362","article-title":"Immunological pathomechanisms in vitiligo","volume":"2001","author":"Kemp","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"10.1038\/jid.2008.31_bb0020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.31_bb0025","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","article-title":"Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo","volume":"117","author":"Le Gal","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.31_bb0030","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2008.31_bb0035","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.31_bb0040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.31_bb0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of naive Melan-A\/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2008.31_bb0050","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.4049\/jimmunol.166.12.7634","article-title":"Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases","volume":"166","author":"Pittet","year":"2001","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.31_bb0055","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4049\/jimmunol.167.3.1188","article-title":"Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC","volume":"167","author":"Salio","year":"2001","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.31_bb0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00262-005-0042-5","article-title":"Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2","volume":"55","author":"Steitz","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/jid.2008.31_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I","article-title":"Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma","volume":"86","author":"Steitz","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2008.31_bb0070","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"Valmori","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.31_bb0075","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"Van den Wijngaard","year":"2000","journal-title":"Lab Invest"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15339804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15339804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:33:20Z","timestamp":1684287200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15339804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0022202X15339804"],"URL":"https:\/\/doi.org\/10.1038\/jid.2008.31","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}